However, in the PCC16 treatment group, there was a significant decline in both tumor weight and size compared to the control group, as well as the BMS-8 and PD-L1 monoclonal antibody treatment groups (P < 0.05) (Fig. 7C, E). Here, CD274 is linked to neoplasm.